{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie6um2yqrhaac7pkj3zs7hoh7365lju36mnnlxvtsy3xog5l5xave",
    "uri": "at://did:plc:nnaxwirbqywidimahadp42bj/app.bsky.feed.post/3mkj24di3vn22"
  },
  "path": "/aviadobio-announces-agreement-with-apertura-gene-therapy-to-license-tfr1-capx-a-next-generation-blood-brain-barrier-crossing-capsid/",
  "publishedAt": "2026-04-27T21:04:11.000Z",
  "site": "https://www.cityam.com",
  "tags": [
    "Contract/Agreement"
  ],
  "textContent": "AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one-time gene silencing in the central nervous system AviadoBio will present key data on AVB-406 at the upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting",
  "title": "AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid"
}